Citations (155)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Matthew T Balmer, Ryan D Katz, Si Liao, James S Goodwine & Susannah Gal. (2014) Doxorubicin and 5-fluorouracil induced accumulation and transcriptional activity of p53 are independent of the phosphorylation at serine 15 in MCF-7 breast cancer cells. Cancer Biology & Therapy 15:8, pages 1000-1012.
Read now
Read now
Karen A Boehme & Christine Blattner. (2009) Regulation of p53 - insights into a complex process. Critical Reviews in Biochemistry and Molecular Biology 44:6, pages 367-392.
Read now
Read now
Yetao Jin, Shelya X. Zeng, Xiao-Xin Sun, Hunjoo Lee, Christine Blattner, Zhixiong Xiao & Hua Lu. (2008) MDMX Promotes Proteasomal Turnover of p21 at G1 and Early S Phases Independently of, but in Cooperation with, MDM2. Molecular and Cellular Biology 28:4, pages 1218-1229.
Read now
Read now
Jason D. Grier, Shunbin Xiong, Ana C. Elizondo-Fraire, John M. Parant & Guillermina Lozano. (2006) Tissue-Specific Differences of p53 Inhibition by Mdm2 and Mdm4. Molecular and Cellular Biology 26:1, pages 192-198.
Read now
Read now
Koji Okamoto, Kenji Kashima, Yaron Pereg, Michiko Ishida, Satomi Yamazaki, Ayumi Nota, Amina Teunisse, Domenico Migliorini, Issay Kitabayashi, Jean-Christophe Marine, Carol Prives, Yosef Shiloh, Aart G. Jochemsen & Yoichi Taya. (2005) DNA Damage-Induced Phosphorylation of MdmX at Serine 367 Activates p53 by Targeting MdmX for Mdm2-Dependent Degradation. Molecular and Cellular Biology 25:21, pages 9608-9620.
Read now
Read now
Mu-Shui Dai, Shelya X. Zeng, Yetao Jin, Xiao-Xin Sun, Larry David & Hua Lu. (2004) Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation Inhibition. Molecular and Cellular Biology 24:17, pages 7654-7668.
Read now
Read now
Yanping Zhang, Gabrielle White Wolf, Krishna Bhat, Aiwen Jin, Theresa Allio, William A. Burkhart & Yue Xiong. (2003) Ribosomal Protein L11 Negatively Regulates Oncoprotein MDM2 and Mediates a p53-Dependent Ribosomal-Stress Checkpoint Pathway. Molecular and Cellular Biology 23:23, pages 8902-8912.
Read now
Read now
Heng-Yin Yang, Yu-Ye Wen, Chih-Hsin Chen, Guillermina Lozano & Mong-Hong Lee. (2003) 14-3-3σ Positively Regulates p53 and Suppresses Tumor Growth. Molecular and Cellular Biology 23:20, pages 7096-7107.
Read now
Read now
Yu Pan & Jiandong Chen. (2003) MDM2 Promotes Ubiquitination and Degradation of MDMX. Molecular and Cellular Biology 23:15, pages 5113-5121.
Read now
Read now
Erik Meulmeester, Ruth Frenk, Robert Stad, Petra de Graaf, Jean-Christophe Marine, Karen H. Vousden & Aart G. Jochemsen. (2003) Critical Role for a Central Part of Mdm2 in the Ubiquitylation of p53. Molecular and Cellular Biology 23:14, pages 4929-4938.
Read now
Read now
Changgong Li, Lihong Chen & Jiandong Chen. (2002) DNA Damage Induces MDMX Nuclear Translocation by p53-Dependent and -Independent Mechanisms. Molecular and Cellular Biology 22:21, pages 7562-7571.
Read now
Read now
Domenico Migliorini, Eros Lazzerini Denchi, Davide Danovi, Aart Jochemsen, Manuela Capillo, Alberto Gobbi, Kristian Helin, Pier Giuseppe Pelicci & Jean-Christophe Marine. (2002) Mdm4 (Mdmx) Regulates p53-Induced Growth Arrest and Neuronal Cell Death during Early Embryonic Mouse Development. Molecular and Cellular Biology 22:15, pages 5527-5538.
Read now
Read now
Articles from other publishers (143)
Douglas W. Brown, Perrin H. Beatty & John D. Lewis. (2022) Molecular Targeting of the Most Functionally Complex Gene in Precision Oncology: p53. Cancers 14:21, pages 5176.
Crossref
Crossref
Heng Jiang, Jing Luo & Hetian Lei. (2022) The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review. Experimental Eye Research 217, pages 108910.
Crossref
Crossref
Jack D. Sanford, Jing Yang, Jing Han, Laura A. Tollini, Aiwen Jin & Yanping Zhang. (2021) MDMX is essential for the regulation of p53 protein levels in the absence of a functional MDM2 C-terminal tail. BMC Molecular and Cell Biology 22:1.
Crossref
Crossref
Jing Qu, Shan-Zhong Yang, Yi Zhu, Ting Guo, Victor J. Thannickal & Yong Zhou. (2021) Targeting mechanosensitive MDM4 promotes lung fibrosis resolution in aged mice. Journal of Experimental Medicine 218:5.
Crossref
Crossref
Jing Yang, Aiwen Jin, Jing Han, Xin Chen, Junnian Zheng & Yanping Zhang. (2021)
MDMX Recruits UbcH5c to Facilitate MDM2 E3 Ligase Activity and Subsequent p53 Degradation
In Vivo
. Cancer Research 81:4, pages 898-909.
Crossref
Crossref
Marta Falcicchio, Jake A. Ward, Salvador Macip & Richard G. Doveston. (2020) Regulation of p53 by the 14-3-3 protein interaction network: new opportunities for drug discovery in cancer. Cell Death Discovery 6:1.
Crossref
Crossref
Ji Hoon Jung, Hyemin Lee, Shelya X Zeng & Hua Lu. (2020) RBM10, a New Regulator of p53. Cells 9:9, pages 2107.
Crossref
Crossref
Sue Haupt, Javier Octavio Mejía-Hernández, Reshma Vijayakumaran, Simon P Keam & Ygal Haupt. (2019) The long and the short of it: the MDM4 tail so far. Journal of Molecular Cell Biology 11:3, pages 231-244.
Crossref
Crossref
Chi-Che Hsieh & Che-Hung Shen. (2019) The Potential of Targeting P53 and HSP90 Overcoming Acquired MAPKi-Resistant Melanoma. Current Treatment Options in Oncology 20:3.
Crossref
Crossref
Stephen Ohms, Jane E. Dahlstrom & Danny Rangasamy. 2018. Gene Expression and Regulation in Mammalian Cells - Transcription Toward the Establishment of Novel Therapeutics. Gene Expression and Regulation in Mammalian Cells - Transcription Toward the Establishment of Novel Therapeutics.
Jane Vin Chan, Dawn Xin Ping Koh, Yun Liu, Thomas L. Joseph, David P. Lane, Chandra S. Verma & Yaw Sing Tan. (2017) Role of the N-terminal lid in regulating the interaction of phosphorylated MDMX with p53. Oncotarget 8:68, pages 112825-112840.
Crossref
Crossref
Hui Tian, Nicole R. Tackmann, Aiwen Jin, Junnian Zheng & Yanping Zhang. (2017) Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice. Journal of Biological Chemistry 292:52, pages 21614-21622.
Crossref
Crossref
Koji Nomura, Marta Klejnot, Dominika Kowalczyk, Andreas K Hock, Gary J Sibbet, Karen H Vousden & Danny T Huang. (2017) Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity. Nature Structural & Molecular Biology 24:7, pages 578-587.
Crossref
Crossref
Yingxiao Chen, Yue-Gang Wang, Yuhuang Li, Xiao-Xin Sun & Mu-Shui Dai. (2016) Otub1 stabilizes MDMX and promotes its proapoptotic function at the mitochondria. Oncotarget 8:7, pages 11053-11062.
Crossref
Crossref
Nicole R. Tackmann & Yanping Zhang. (2017) Mouse modelling of the MDM2/MDMX−p53 signalling axis. Journal of Molecular Cell Biology 9:1, pages 34-44.
Crossref
Crossref
Z Matijasevic, A Krzywicka-Racka, G Sluder, J Gallant & S N Jones. (2016) The Zn-finger domain of MdmX suppresses cancer progression by promoting genome stability in p53-mutant cells. Oncogenesis 5:10, pages e262-e262.
Crossref
Crossref
Michael I. Carr, Justine E. Roderick, Hugh S. Gannon, Michelle A. Kelliher & Stephen N. Jones. (2016) Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis. Cell Reports 16:10, pages 2618-2629.
Crossref
Crossref
T. Longerich. (2014) EEF1A2 inhibiert über eine PI3K/AKT/mTOR-abhängige Stabilisierung von MDM4 die p53-Funktion im LeberzellkarzinomEEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4. Der Pathologe 35:S2, pages 177-184.
Crossref
Crossref
S-M Hede, V Savov, H Weishaupt, O Sangfelt & F J Swartling. (2013) Oncoprotein stabilization in brain tumors. Oncogene 33:39, pages 4709-4721.
Crossref
Crossref
Sara Proietti, Alessandra Cucina, Gabriella Dobrowolny, Fabrizio D'Anselmi, Simona Dinicola, Maria Grazia Masiello, Alessia Pasqualato, Alessandro Palombo, Veronica Morini, Russel J. Reiter & Mariano Bizzarri. (2014) Melatonin down-regulates MDM2 gene expression and enhances p53 acetylation in MCF-7 cells. Journal of Pineal Research 57:1, pages 120-129.
Crossref
Crossref
Laura A. Tollini, Aiwen Jin, Jikyoung Park & Yanping Zhang. (2014) Regulation of p53 by Mdm2 E3 Ligase Function Is Dispensable in Embryogenesis and Development, but Essential in Response to DNA Damage. Cancer Cell 26:2, pages 235-247.
Crossref
Crossref
Chun-Lin Wang, Jun-Yu Wang, Zhen-Yang Liu, Xiao-Mei Ma, Xiao-Wen Wang, Hai Jin, Xiao-Ping Zhang, Da Fu, Li-Jun Hou & Yi-Cheng Lu. (2014) Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma. Carcinogenesis 35:7, pages 1500-1509.
Crossref
Crossref
Nadi T. Wickramasekera & Gokul M. Das. (2014) Tumor suppressor p53 and estrogen receptors in nuclear–mitochondrial communication. Mitochondrion 16, pages 26-37.
Crossref
Crossref
Steven J. Berberich. 2014. Mutant p53 and MDM2 in Cancer. Mutant p53 and MDM2 in Cancer
263
280
.
Nader Touqan, Christine P Diggle, Edlo T Verghese, Sarah Perry, Kieran Horgan, William Merchant, Rashida Anwar, Alexander F Markham, Ian M Carr & Rajgopal Achuthan. (2013) An observational study on the expression levels of MDM2 and MDMX proteins, and associated effects on P53 in a series of human liposarcomas. BMC Clinical Pathology 13:1.
Crossref
Crossref
Linda Vuong, Daniel E. Brobst, Ivana Ivanovic, David M. Sherry & Muayyad R. Al-Ubaidi. (2013) p53 Selectively Regulates Developmental Apoptosis of Rod Photoreceptors. PLoS ONE 8:6, pages e67381.
Crossref
Crossref
X Zhang, W Wang, H Wang, M-H Wang, W Xu & R Zhang. (2012) Identification of ribosomal protein S25 (RPS25)–MDM2–p53 regulatory feedback loop. Oncogene 32:22, pages 2782-2791.
Crossref
Crossref
Tamara Terzian & Guillermina Lozano. 2013. p53 in the Clinics. p53 in the Clinics
77
93
.
Rocky Cipriano, James Graham, Kristy L.S. Miskimen, Benjamin L. Bryson, Ronald C. Bruntz, Sarah A. Scott, H. Alex Brown, George R. Stark & Mark W. Jackson. (2012) FAM83B mediates EGFR- and RAS-driven oncogenic transformation. Journal of Clinical Investigation 122:9, pages 3197-3210.
Crossref
Crossref
Xinjiang Wang & Xuejun Jiang. (2012) Mdm2 and MdmX partner to regulate p53. FEBS Letters 586:10, pages 1390-1396.
Crossref
Crossref
Dongsheng Pei, Yanping Zhang & Junnian Zheng. (2012) Regulation of p53: a collaboration between Mdm2 and MdmX. Oncotarget 3:3, pages 228-235.
Crossref
Crossref
Jianzhong Chen, Dinglin Zhang, Yuxin Zhang & Guohui Li. (2012) Computational Studies of Difference in Binding Modes of Peptide and Non-Peptide Inhibitors to MDM2/MDMX Based on Molecular Dynamics Simulations. International Journal of Molecular Sciences 13:2, pages 2176-2195.
Crossref
Crossref
Jacqueline Boultwood, Andrea Pellagatti & James S. Wainscoat. (2012) Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome. Advances in Biological Regulation 52:1, pages 196-203.
Crossref
Crossref
Yuan Yuan, Yu-Min Liao, Chung-Tsen Hsueh & Hamid R Mirshahidi. (2011) Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP. Journal of Hematology & Oncology 4:1.
Crossref
Crossref
Lorenzo GalluzziEugenia MorselliOliver KeppIlio VitaleMarcello PintiGuido Kroemer. (2011) Mitochondrial Liaisons of p53. Antioxidants & Redox Signaling 15:6, pages 1691-1714.
Crossref
Crossref
Vinod Pant, Shunbin Xiong, Tomoo Iwakuma, Alfonso Quintás-Cardama & Guillermina Lozano. (2011) Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability. Proceedings of the National Academy of Sciences 108:29, pages 11995-12000.
Crossref
Crossref
Xinjiang Wang, Junru Wang & Xuejun Jiang. (2011) MdmX Protein Is Essential for Mdm2 Protein-mediated p53 Polyubiquitination. Journal of Biological Chemistry 286:27, pages 23725-23734.
Crossref
Crossref
Yuan Xiao Zhu, Rodger Tiedemann, Chang-Xin Shi, Holly Yin, Jessica E. Schmidt, Laura A. Bruins, Jonathan J. Keats, Esteban Braggio, Chris Sereduk, Spyro Mousses & A. Keith Stewart. (2011) RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5. Blood 117:14, pages 3847-3857.
Crossref
Crossref
Luyang Sun, Lei Shi, Feng Wang, Peiwei Huangyang, Wenzhe Si, Jie Yang, Zhi Yao & Yongfeng Shang. (2011) Substrate Phosphorylation and Feedback Regulation in JFK-promoted p53 Destabilization. Journal of Biological Chemistry 286:6, pages 4226-4235.
Crossref
Crossref
Jonathan Shloush, John E. Vlassov, Ian Engson, Shili Duan, Vivian Saridakis, Sirano Dhe-paganon, Brian Raught, Yi Sheng & Cheryl H. Arrowsmith. (2011) Structural and Functional Comparison of the RING Domains of Two p53 E3 Ligases, Mdm2 and Pirh2. Journal of Biological Chemistry 286:6, pages 4796-4808.
Crossref
Crossref
David L. Waning, Jason A. Lehman, Christopher N. Batuello & Lindsey D. Mayo. (2011) c-Abl Phosphorylation of Mdm2 Facilitates Mdm2-Mdmx Complex Formation. Journal of Biological Chemistry 286:1, pages 216-222.
Crossref
Crossref
Antonio Macchiarulo, Nicola Giacchè, Andrea Carotti, Fabiola Moretti & Roberto Pellicciari. (2011) Expanding the horizon of chemotherapeutic targets: From MDM2 to MDMX (MDM4). MedChemComm 2:6, pages 455.
Crossref
Crossref
Jean-Christophe Marine. 2011. Cancer and Development. Cancer and Development
45
75
.
Lan Wang, Guifen He, Pingzhao Zhang, Xiang Wang, Mei Jiang & Long Yu. (2010) Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53. Molecular Biology Reports 38:1, pages 229-236.
Crossref
Crossref
Feroz Sarkari, Anthony La Delfa, Cheryl H. Arrowsmith, Lori Frappier, Yi Sheng & Vivian Saridakis. (2010) Further Insight into Substrate Recognition by USP7: Structural and Biochemical Analysis of the HdmX and Hdm2 Interactions with USP7. Journal of Molecular Biology 402:5, pages 825-837.
Crossref
Crossref
A. Molchadsky, N. Rivlin, R. Brosh, V. Rotter & R. Sarig. (2010) p53 is balancing development, differentiation and de-differentiation to assure cancer prevention. Carcinogenesis 31:9, pages 1501-1508.
Crossref
Crossref
Wuguo Chen, Isaac B. Hilton, Michelle R. Staudt, Christin E. Burd & Dirk P. Dittmer. (2010) Distinct p53, p53:LANA, and LANA Complexes in Kaposi's Sarcoma-Associated Herpesvirus Lymphomas. Journal of Virology 84:8, pages 3898-3908.
Crossref
Crossref
Damon Reed, Ying Shen, Anang A. Shelat, Leggy A. Arnold, Antonio M. Ferreira, Fangyi Zhu, Nicholas Mills, David C. Smithson, Catherine A. Regni, Donald Bashford, Samantha A. Cicero, Brenda A. Schulman, Aart G. Jochemsen, R. Kiplin Guy & Michael A. Dyer. (2010) Identification and Characterization of the First Small Molecule Inhibitor of MDMX. Journal of Biological Chemistry 285:14, pages 10786-10796.
Crossref
Crossref
Ingunn W. Jolma, Xiao Yu Ni, Ludger Rensing & Peter Ruoff. (2010) Harmonic Oscillations in Homeostatic Controllers: Dynamics of the p53 Regulatory System. Biophysical Journal 98:5, pages 743-752.
Crossref
Crossref
Sohyoung Kim, Mirit I. Aladjem, Geoffrey B. McFadden & Kurt W. Kohn. (2010) Predicted Functions of MdmX in Fine-Tuning the Response of p53 to DNA Damage. PLoS Computational Biology 6:2, pages e1000665.
Crossref
Crossref
Nerea Allende-Vega & Mark K. Saville. (2010) Targeting the ubiquitin–proteasome system to activate wild-type p53 for cancer therapy. Seminars in Cancer Biology 20:1, pages 29-39.
Crossref
Crossref
Khaled Barakat, Jonathan Mane, Douglas Friesen & Jack Tuszynski. (2010) Ensemble-based virtual screening reveals dual-inhibitors for the p53–MDM2/MDMX interactions. Journal of Molecular Graphics and Modelling 28:6, pages 555-568.
Crossref
Crossref
Ayeda Ayed & Theodore HuppJeremy Blaydes. 2010. p53. p53
85
99
.
Grzegorz Sarek & Päivi M. Ojala. 2010. Molecular Basis for Therapy of AIDS-Defining Cancers. Molecular Basis for Therapy of AIDS-Defining Cancers
167
180
.
Diptee A. Kulkarni, Alexei Vazquez, Bruce G. Haffty, Elisa V. Bandera, Wenwei Hu, Yvonne Y. Sun, Deborah L. Toppmeyer, Arnold J. Levine & Kim M. Hirshfield. (2009) A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer. Carcinogenesis 30:11, pages 1910-1915.
Crossref
Crossref
Yanping Zhang & Hua Lu. (2009) Signaling to p53: Ribosomal Proteins Find Their Way. Cancer Cell 16:5, pages 369-377.
Crossref
Crossref
Christiane RiedingerJames M McDonnell. (2009) Inhibitors of MDM2 and MDMX: a structural perspective. Future Medicinal Chemistry 1:6, pages 1075-1094.
Crossref
Crossref
Francesca Mancini, Giusy Di Conza, Marsha Pellegrino, Cinzia Rinaldo, Andrea Prodosmo, Simona Giglio, Igea D'Agnano, Fulvio Florenzano, Lara Felicioni, Fiamma Buttitta, Antonio Marchetti, Ada Sacchi, Alfredo Pontecorvi, Silvia Soddu & Fabiola Moretti. (2009) MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. The EMBO Journal 28:13, pages 1926-1939.
Crossref
Crossref
Yasmine A. Valentin-Vega, Neil Box, Tamara Terzian & Guillermina Lozano. (2009) Mdm4 loss in the intestinal epithelium leads to compartmentalized cell death but no tissue abnormalities. Differentiation 77:5, pages 442-449.
Crossref
Crossref
San San Lee, Nai Yang Fu, Sunil K. Sukumaran, Kah Fei Wan, Qian Wan & Victor C. Yu. (2009) TRIM39 is a MOAP-1-binding protein that stabilizes MOAP-1 through inhibition of its poly-ubiquitination process. Experimental Cell Research 315:7, pages 1313-1325.
Crossref
Crossref
Marzena PazgierMin Liu, Guozhang ZouWeirong YuanChangqing LiChong LiJing LiJuahdi MonboDavide ZellaSergey G. Tarasov & Wuyuan Lu. (2009) Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX. Proceedings of the National Academy of Sciences 106:12, pages 4665-4670.
Crossref
Crossref
Sanjeev ShangaryShaomeng Wang. (2009) Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy. Annual Review of Pharmacology and Toxicology 49:1, pages 223-241.
Crossref
Crossref
Shaoman Yin & Erwin G. Van Meir. 2009. CNS Cancer. CNS Cancer
283
314
.
Nancy Smyth TempletonMu-Shui Dai, Jayme Gallegos & Hua Lu. 2008. Gene and Cell Therapy. Gene and Cell Therapy.
Jong-Hee Lee, Min-Woo Jeong, Wanil Kim, Yoon Ha Choi & Kyong-Tai Kim. (2008) Cooperative Roles of c-Abl and Cdk5 in Regulation of p53 in Response to Oxidative Stress. Journal of Biological Chemistry 283:28, pages 19826-19835.
Crossref
Crossref
Juan A. Barboza, Tomoo Iwakuma, Tamara Terzian, Adel K. El-Naggar & Guillermina Lozano. (2008)
Mdm2
and
Mdm4
Loss Regulates Distinct p53 Activities
. Molecular Cancer Research 6:6, pages 947-954.
Crossref
Crossref
Vanessa Lopez-Pajares, Mihee M. Kim & Zhi-Min Yuan. (2008) Phosphorylation of MDMX Mediated by Akt Leads to Stabilization and Induces 14-3-3 Binding. Journal of Biological Chemistry 283:20, pages 13707-13713.
Crossref
Crossref
Christian Klein & Lyubomir T. Vassilev. 2008. Checkpoint Responses in Cancer Therapy. Checkpoint Responses in Cancer Therapy
19
56
.
P. M. Chumakov. (2007) Versatile functions of p53 protein in multicellular organisms. Biochemistry (Moscow) 72:13, pages 1399-1421.
Crossref
Crossref
Dimitris P. Xirodimas. 2007. Protein Degradation. Protein Degradation
21
45
.
Yasmine A. Valentin-Vega, Juan A. Barboza, Gilda P. Chau, Adel K. El-Naggar & Guillermina Lozano. (2007) High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomas. Human Pathology 38:10, pages 1553-1562.
Crossref
Crossref
Koji Itahana, Hua Mao, Aiwen Jin, Yoko Itahana, Hilary V. Clegg, Mikael S. Lindström, Krishna P. Bhat, Virginia L. Godfrey, Gerard I. Evan & Yanping Zhang. (2007) Targeted Inactivation of Mdm2 RING Finger E3 Ubiquitin Ligase Activity in the Mouse Reveals Mechanistic Insights into p53 Regulation. Cancer Cell 12:4, pages 355-366.
Crossref
Crossref
Christoph R. Müller, Erik B. Paulsen, Paul Noordhuis, Florence Pedeutour, Gunnar Saeter & Ola Myklebost. (2007) Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A. International Journal of Cancer 121:1, pages 199-205.
Crossref
Crossref
Christian Kannemeier, Rong Liao & Peiqing Sun. (2007) The RING Finger Domain of MDM2 Is Essential for MDM2-mediated TGF-β Resistance. Molecular Biology of the Cell 18:6, pages 2367-2377.
Crossref
Crossref
Mi-Sung Kim, Sang Min Lee, Won Dong Kim, Sung Hwan Ki, Aree Moon, Chang Ho Lee & Sang Geon Kim. (2007) Gα12/13 Basally Regulates p53 through Mdm4 Expression. Molecular Cancer Research 5:5, pages 473-484.
Crossref
Crossref
Rajesh K. Singh, Saravanakumar Iyappan & Martin Scheffner. (2007) Hetero-oligomerization with MdmX Rescues the Ubiquitin/Nedd8 Ligase Activity of RING Finger Mutants of Mdm2. Journal of Biological Chemistry 282:15, pages 10901-10907.
Crossref
Crossref
H F Horn & K H Vousden. (2007) Coping with stress: multiple ways to activate p53. Oncogene 26:9, pages 1306-1316.
Crossref
Crossref
Jean-Christophe W. Marine, Michael A. Dyer & Aart G. Jochemsen. (2007) MDMX: from bench to bedside. Journal of Cell Science 120:3, pages 371-378.
Crossref
Crossref
K Yoon, S Zhu, S J Ewing & R C Smart. (2006) Decreased survival of C/EBPβ-deficient keratinocytes is due to aberrant regulation of p53 levels and function. Oncogene 26:3, pages 360-367.
Crossref
Crossref
Stjepan Uldrijan, Willem-Jan Pannekoek & Karen H Vousden. (2006) An essential function of the extreme C-terminus of MDM2 can be provided by MDMX. The EMBO Journal 26:1, pages 102-112.
Crossref
Crossref
Geoffrey M. Wahl, Jayne M. Stommel, Kurt Krummel & Mark Wade. 2007. 25 Years of p53 Research. 25 Years of p53 Research
73
113
.
Franck Toledo & Geoffrey M. Wahl. (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nature Reviews Cancer 6:12, pages 909-923.
Crossref
Crossref
Lin Römer, Christian Klein, Alexander Dehner, Horst Kessler & Johannes Buchner. (2006) p53—A Natural Cancer Killer: Structural Insights and Therapeutic Concepts. Angewandte Chemie International Edition 45:39, pages 6440-6460.
Crossref
Crossref
Lin Römer, Christian Klein, Alexander Dehner, Horst Kessler & Johannes Buchner. (2006) p53 – ein natürlicher Krebskiller: Einsichten in die Struktur und Therapiekonzepte. Angewandte Chemie 118:39, pages 6590-6611.
Crossref
Crossref
Wataru Aizu, Glenn S. Belinsky, Christopher Flynn, Emily J. Noonan, Colleen C. Boes, Cassandra A. Godman, Bindi Doshi, Prashant R. Nambiar, Daniel W. Rosenberg & Charles Giardina. (2006) Circumvention and reactivation of the p53 oncogene checkpoint in mouse colon tumors. Biochemical Pharmacology 72:8, pages 981-991.
Crossref
Crossref
M F Lavin & N Gueven. (2006) The complexity of p53 stabilization and activation. Cell Death & Differentiation 13:6, pages 941-950.
Crossref
Crossref
Yetao Jin, Mu-Shui Dai, Steven Z Lu, Yingda Xu, Zhijun Luo, Yingming Zhao & Hua Lu. (2006) 14-3-3γ binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. The EMBO Journal 25:6, pages 1207-1218.
Crossref
Crossref
John T. Patton, Lindsey D. Mayo, Aatur D. Singhi, Andrei V. Gudkov, George R. Stark & Mark W. Jackson. (2006) Levels of HdmX Expression Dictate the Sensitivity of Normal and Transformed Cells to Nutlin-3. Cancer Research 66:6, pages 3169-3176.
Crossref
Crossref
Shunbin Xiong, Carolyn S. Van Pelt, Ana C. Elizondo-Fraire, Geng Liu & Guillermina Lozano. (2006) Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development. Proceedings of the National Academy of Sciences 103:9, pages 3226-3231.
Crossref
Crossref
Christopher L. Brooks & Wei Gu. (2006) p53 Ubiquitination: Mdm2 and Beyond. Molecular Cell 21:3, pages 307-315.
Crossref
Crossref
Christopher L. Brooks & Wei Gu. 2006. Gene Expression and Regulation. Gene Expression and Regulation
257
272
.
Alessandra di Pietro, Elisabeth G.E. de Vries, Jourik A Gietema, Diana C.J. Spierings & Steven de Jong. (2005) Testicular germ cell tumours: The paradigm of chemo-sensitive solid tumours. The International Journal of Biochemistry & Cell Biology 37:12, pages 2437-2456.
Crossref
Crossref
Heather A Steinman, Kathleen M Hoover, Marilyn L Keeler, Arthur T Sands & Stephen N Jones. (2005) Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in development. Oncogene 24:53, pages 7935-7940.
Crossref
Crossref
Errol C. Friedberg, Graham C. Walker, Wolfram Siede, Richard D. Wood, Roger A. Schultz & Tom Ellenberger. 2005. DNA Repair and Mutagenesis. DNA Repair and Mutagenesis
779
815
.
Frank Bartel, Jördis Schulz, Anja Böhnke, Karen Blümke, Matthias Kappler, Matthias Bache, Hannelore Schmidt, Peter Würl, Helge Taubert & Steffen Hauptmann. (2005) Significance ofHDMX-S (orMDM4) mRNA splice variant overexpression andHDMX gene amplification on primary soft tissue sarcoma prognosis. International Journal of Cancer 117:3, pages 469-475.
Crossref
Crossref
Jana Šmardová, Jan Šmarda & Jana Koptíková. (2005) Functional analysis of p53 tumor suppressor in yeast. Differentiation 73:6, pages 261-277.
Crossref
Crossref
Leena Latonen & Marikki Laiho. (2005) Cellular UV damage responses—Functions of tumor suppressor p53. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1755:2, pages 71-89.
Crossref
Crossref
Yaara Levav-Cohen, Zehavit Goldberg, Valentina Zuckerman, Tamar Grossman, Sue Haupt & Ygal Haupt. (2005) C-Abl as a modulator of p53. Biochemical and Biophysical Research Communications 331:3, pages 737-749.
Crossref
Crossref
Jean-Christophe Marine & Aart G. Jochemsen. (2005) Mdmx as an essential regulator of p53 activity. Biochemical and Biophysical Research Communications 331:3, pages 750-760.
Crossref
Crossref
Amanda S. Coutts & Nicholas B. La Thangue. (2005) The p53 response: Emerging levels of co-factor complexity. Biochemical and Biophysical Research Communications 331:3, pages 778-785.
Crossref
Crossref
Daniele Bergamaschi, Yardena Samuels, Shan Zhong & Xin Lu. (2005) Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation. Oncogene 24:23, pages 3836-3841.
Crossref
Crossref
Erik Meulmeester, Madelon M. Maurice, Chris Boutell, Amina F.A.S. Teunisse, Huib Ovaa, Tsion E. Abraham, Roeland W. Dirks & Aart G. Jochemsen. (2005) Loss of HAUSP-Mediated Deubiquitination Contributes to DNA Damage-Induced Destabilization of Hdmx and Hdm2. Molecular Cell 18:5, pages 565-576.
Crossref
Crossref
Yaron Pereg, Dganit Shkedy, Petra de Graaf, Erik Meulmeester, Marina Edelson-Averbukh, Mogjiborahman Salek, Sharon Biton, Amina F. A. S. Teunisse, Wolf D. Lehmann, Aart G. Jochemsen & Yosef Shiloh. (2005) Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage. Proceedings of the National Academy of Sciences 102:14, pages 5056-5061.
Crossref
Crossref
Liqing Wu & Carl G. Maki. 2005. Zinc Finger Proteins. Zinc Finger Proteins
252
260
.
Zheng Li, Chi-Ping Day, Jer-Yen Yang, Wen-Bin Tsai, Guillermina Lozano, Hsiu-Ming Shih & Mien-Chie Hung. (2004) Adenoviral E1A Targets Mdm4 to Stabilize Tumor Suppressor p53. Cancer Research 64:24, pages 9080-9085.
Crossref
Crossref
I.V. Davydov, D. Woods, Y.J. Safiran, P. Oberoi, H.O. Fearnhead, S. Fang, J.P. Jensen, A.M. Weissman, J.H. Kenten & K.H. Vousden. (2004) Assay for Ubiquitin Ligase Activity: High-Throughput Screen for Inhibitors of HDM2. SLAS Discovery 9:8, pages 695-703.
Crossref
Crossref
Helen Rodway, Susana Llanos, Janice Rowe & Gordon Peters. (2004) Stability of nucleolar versus non-nucleolar forms of human p14ARF. Oncogene 23:37, pages 6186-6192.
Crossref
Crossref
Chris Boutell & Roger D. Everett. (2004) Herpes Simplex Virus Type 1 Infection Induces the Stabilization of p53 in a USP7- and ATM-Independent Manner. Journal of Virology 78:15, pages 8068-8077.
Crossref
Crossref
Francesca Mancini, Francesca Gentiletti, Marco D'Angelo, Simona Giglio, Simona Nanni, Carmen D'Angelo, Antonella Farsetti, Gennaro Citro, Ada Sacchi, Alfredo Pontecorvi & Fabiola Moretti. (2004) MDM4 (MDMX) Overexpression Enhances Stabilization of Stress-induced p53 and Promotes Apoptosis. Journal of Biological Chemistry 279:9, pages 8169-8180.
Crossref
Crossref
Tsuyoshi Akagi, Ken Sasai & Hidesaburo Hanafusa. (2003) Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation. Proceedings of the National Academy of Sciences 100:23, pages 13567-13572.
Crossref
Crossref
Laëtitia K. Linares, Arnd Hengstermann, Aaron Ciechanover, Stefan Müller & Martin Scheffner. (2003) HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. Proceedings of the National Academy of Sciences 100:21, pages 12009-12014.
Crossref
Crossref
Petra de Graaf, Natalie A. Little, Yolande F.M. Ramos, Erik Meulmeester, Stef J.F. Letteboer & Aart G. Jochemsen. (2003) Hdmx Protein Stability Is Regulated by the Ubiquitin Ligase Activity of Mdm2. Journal of Biological Chemistry 278:40, pages 38315-38324.
Crossref
Crossref
Ravikumar Rallapalli, Gordon Strachan, Rocky S. Tuan & David J. Hall. (2003) Identification of a domain within MDMX-S that is responsible for its high affinity interaction with p53 and high-level expression in mammalian cells. Journal of Cellular Biochemistry 89:3, pages 563-575.
Crossref
Crossref
Roger P. Leng, Yunping Lin, Weili Ma, Hong Wu, Benedicte Lemmers, Stephen Chung, John M. Parant, Guillermina Lozano, Razqallah Hakem & Samuel Benchimol. (2003) Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation. Cell 112:6, pages 779-791.
Crossref
Crossref
John M. Parant & Guillermina Lozano. (2003) DisruptingTP53 in mouse models of human cancers. Human Mutation 21:3, pages 321-326.
Crossref
Crossref
Shengyun Fang, Kevin L. Lorick, Jane P. Jensen & Allan M. Weissman. (2003) RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer. Seminars in Cancer Biology 13:1, pages 5-14.
Crossref
Crossref
Dania Alarcon Vargas, Shoichi Takahashi & Ze'ev Ronai. 2003.
1
34
.
Madhavi Kadakia, Thomas L Brown, Molly M McGorry & Steven J Berberich. (2002) MdmX inhibits Smad transactivation. Oncogene 21:57, pages 8776-8785.
Crossref
Crossref
James C. Badciong & Arthur L. Haas. (2002) MdmX Is a RING Finger Ubiquitin Ligase Capable of Synergistically Enhancing Mdm2 Ubiquitination. Journal of Biological Chemistry 277:51, pages 49668-49675.
Crossref
Crossref
Todd R Pray, Francesco Parlati, Jianing Huang, Brian R Wong, Donald G Payan, Mark K Bennett, Sarkiz Daniel Issakani, Susan Molineaux & Susan D Demo. (2002) Cell cycle regulatory E3 ubiquitin ligases as anticancer targets. Drug Resistance Updates 5:6, pages 249-258.
Crossref
Crossref
Peter SabbatiniFrank McCormick. (2002) MDMX Inhibits the p300/CBP-Mediated Acetylation of p53. DNA and Cell Biology 21:7, pages 519-525.
Crossref
Crossref
Mark Wunderlich & Steven J Berberich. (2002) Mdm2 inhibition of p53 induces E2F1 transactivation via p21. Oncogene 21:28, pages 4414-4421.
Crossref
Crossref
Jijie Gu, Hidehiko Kawai, Linghu Nie, Hiroyuki Kitao, Dmitri Wiederschain, Aart G. Jochemsen, John Parant, Guillermina Lozano & Zhi-Min Yuan. (2002) Mutual Dependence of MDM2 and MDMX in Their Functional Inactivation of p53. Journal of Biological Chemistry 277:22, pages 19251-19254.
Crossref
Crossref
Domenico Migliorini, Davide Danovi, Emanuela Colombo, Roberta Carbone, Pier Giuseppe Pelicci & Jean-Christophe Marine. (2002) Hdmx Recruitment into the Nucleus by Hdm2 Is Essential for Its Ability to Regulate p53 Stability and Transactivation. Journal of Biological Chemistry 277:9, pages 7318-7323.
Crossref
Crossref
Karen H Vousden. (2002) Activation of the p53 tumor suppressor protein. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1602:1, pages 47-59.
Crossref
Crossref
Alexandra Eichten, Matthew Westfall, Jennifer A. Pietenpol & Karl Münger. (2002) Stabilization and Functional Impairment of the Tumor Suppressor p53 by the Human Papillomavirus Type 16 E7 Oncoprotein. Virology 295:1, pages 74-85.
Crossref
Crossref
Francesca Gentiletti, Francesca Mancini, Marco D'Angelo, Ada Sacchi, Alfredo Pontecorvi, Aart G Jochemsen & Fabiola Moretti. (2002) MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts. Oncogene 21:6, pages 867-877.
Crossref
Crossref
Gordon D. Strachan, Ravikumar Rallapalli, Bruna Pucci, Toulouse P. Lafond & David J. Hall. (2001) A Transcriptionally Inactive E2F-1 Targets the MDM Family of Proteins for Proteolytic Degradation. Journal of Biological Chemistry 276:49, pages 45677-45685.
Crossref
Crossref
Robert Stad, Natalie A Little, Dimitris P Xirodimas, Ruth Frenk, Alex J van der Eb, David P Lane, Mark K Saville & Aart G Jochemsen. (2001) Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms. EMBO reports 2:11, pages 1029-1034.
Crossref
Crossref
Sagar Sengupta & Bohdan Wasylyk. (2001) Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. Genes & Development 15:18, pages 2367-2380.
Crossref
Crossref
John Parant, Arturo Chavez-Reyes, Natalie A. Little, Wen Yan, Valerie Reinke, Aart G. Jochemsen & Guillermina Lozano. (2001) Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nature Genetics 29:1, pages 92-95.
Crossref
Crossref
Natalie A Little & Aart G Jochemsen. (2001) Hdmx and Mdm2 can repress transcription activation by p53 but not by p63. Oncogene 20:33, pages 4576-4580.
Crossref
Crossref
Elizabeth A. Maher, Frank B. Furnari, Robert M. Bachoo, David H. Rowitch, David N. Louis, Webster K. Cavenee & Ronald A. DePinho. (2001) Malignant glioma: genetics and biology of a grave matter. Genes & Development 15:11, pages 1311-1333.
Crossref
Crossref
Madhavi Kadakia, Charlotte Slader & Steven J. Berberich. (2001) Regulation of p63 Function by Mdm2 and MdmX. DNA and Cell Biology 20:6, pages 321-330.
Crossref
Crossref
Jennifer S. Isaacs, Shin'ichi Saito & Leonard M. Neckers. (2001) Requirement for HDM2 Activity in the Rapid Degradation of p53 in Neuroblastoma. Journal of Biological Chemistry 276:21, pages 18497-18506.
Crossref
Crossref
Allan M. Weissman. (2001) Themes and variations on ubiquitylation. Nature Reviews Molecular Cell Biology 2:3, pages 169-178.
Crossref
Crossref
Douglas B. Woods & Karen H. Vousden. (2001) Regulation of p53 Function. Experimental Cell Research 264:1, pages 56-66.
Crossref
Crossref
Toshiyuki Kojima, Yoji Ikawa & Iyoko Katoh. (2001) Analysis of Molecular Interactions of the p53-Family p51(p63) Gene Products in a Yeast Two-Hybrid System: Homotypic and Heterotypic Interactions and Association with p53-Regulatory Factors. Biochemical and Biophysical Research Communications 281:5, pages 1170-1175.
Crossref
Crossref
XiaoQi Wang, Talha Arooz, Wai Yi Siu, Clarissa H.S Chiu, Anita Lau, Katsumi Yamashita & Randy Y.C Poon. (2001) MDM2 and MDMX can interact differently with ARF and members of the p53 family. FEBS Letters 490:3, pages 202-208.
Crossref
Crossref
Mark W. Jackson, Mikael S. Lindström & Steven J. Berberich. (2001) MdmX Binding to ARF Affects Mdm2 Protein Stability and p53 Transactivation. Journal of Biological Chemistry 276:27, pages 25336-25341.
Crossref
Crossref
Gitali Ganguli, Joseph Abecassis & Bohdan Wasylyk. (2000) MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis. The EMBO Journal 19:19, pages 5135-5147.
Crossref
Crossref
Robert Stad, Yolande F.M. Ramos, Natalie Little, Shula Grivell, Joline Attema, Alex J. van der Eb & Aart G. Jochemsen. (2000) Hdmx Stabilizes Mdm2 and p53. Journal of Biological Chemistry 275:36, pages 28039-28044.
Crossref
Crossref
Marion A.E Lohrum & Karen H Vousden. (2000) Regulation and function of the p53-related proteins: same family, different rules. Trends in Cell Biology 10:5, pages 197-202.
Crossref
Crossref